FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3132169997> ?p ?o ?g. }

• W3132169997 endingPage "693" @default.
• W3132169997 startingPage "693" @default.
• W3132169997 abstract "A few studies suggested high stereo-specifically numbered (sn)-2 palmitate in a formula might favor the gut Bifidobacteria of infants. The initial colonization and subsequent development of gut microbiota in early life might be associated with development and later life functions of the central nervous system via the microbiota–gut–brain axis, such as children with autism. This study aims to assess the hypothesized effect of increasing the amount of palmitic acid esterified in the sn-2 position in infant formula on neurodevelopment in healthy full-term infants and to explore the association of this effect with the altered gut Bifidobacteria. One hundred and ninety-nine infants were enrolled in this cluster randomized clinical trial: 66 breast-fed (BF group) and 133 formula-fed infants who were clustered and randomly assigned to receive formula containing high sn-2 palmitate (sn-2 group, n = 66) or low sn-2 palmitate (control group, n = 67), where 46.3% and 10.3% of the palmitic acid (PA) was sn-2-palmitate, respectively. Infants’ neurodevelopmental outcomes were measured by the Ages and Stages Questionnaire, third edition (ASQ-3). Stool samples were collected for the analysis of Bifidobacteria (Trial registration number: ChiCTR1800014479). At week 16, the risk of scoring close to the threshold for fine motor skills (reference: scoring above the typical development threshold) was significantly lower in the sn-2 group than the control group after adjustment for the maternal education level (p = 0.036) but did not differ significantly versus the BF group (p = 0.513). At week 16 and week 24, the sn-2 group (week 16: 15.7% and week 24: 15.6%) had a significantly higher relative abundance of fecal Bifidobacteria than the control group (week 16: 6.6%, p = 0.001 and week 24:11.2%, p = 0.028) and did not differ from the BF group (week 16: 14.4%, p = 0.674 and week 24: 14.9%, p = 0.749). At week 16, a higher relative abundance of Bifidobacteria was associated with the decreased odds of only one domain scoring close to the threshold in the formula-fed infants group (odds ratio (OR), 95% confidence interval (CI): 0.947 (0.901–0.996)). Elevating the sn-2 palmitate level in the formula improved infants’ development of fine motor skills, and the beneficial effects of high sn-2 palmitate on infant neurodevelopment was associated with the increased gut Bifidobacteria level." @default.
• W3132169997 created "2021-03-01" @default.
• W3132169997 creator A5012008021 @default.
• W3132169997 creator A5012677271 @default.
• W3132169997 creator A5016410321 @default.
• W3132169997 creator A5027463044 @default.
• W3132169997 creator A5042183753 @default.
• W3132169997 creator A5084359125 @default.
• W3132169997 creator A5084461411 @default.
• W3132169997 date "2021-02-22" @default.
• W3132169997 modified "2023-09-27" @default.
• W3132169997 title "Neurodevelopmental Outcomes and Gut Bifidobacteria in Term Infants Fed an Infant Formula Containing High sn-2 Palmitate: A Cluster Randomized Clinical Trial" @default.
• W3132169997 cites W1600138488 @default.
• W3132169997 cites W1863765650 @default.
• W3132169997 cites W1967466570 @default.
• W3132169997 cites W1969615942 @default.
• W3132169997 cites W1972237932 @default.
• W3132169997 cites W1978357726 @default.
• W3132169997 cites W2008398629 @default.
• W3132169997 cites W2036673372 @default.
• W3132169997 cites W2044437571 @default.
• W3132169997 cites W2047798386 @default.
• W3132169997 cites W2063744942 @default.
• W3132169997 cites W2068888734 @default.
• W3132169997 cites W2091588484 @default.
• W3132169997 cites W2102153351 @default.
• W3132169997 cites W2113568182 @default.
• W3132169997 cites W2115599658 @default.
• W3132169997 cites W2115800464 @default.
• W3132169997 cites W2162088497 @default.
• W3132169997 cites W2164846935 @default.
• W3132169997 cites W2359274148 @default.
• W3132169997 cites W2409509685 @default.
• W3132169997 cites W2548933161 @default.
• W3132169997 cites W2584228070 @default.
• W3132169997 cites W2593775879 @default.
• W3132169997 cites W2730563215 @default.
• W3132169997 cites W2733509553 @default.
• W3132169997 cites W2766853085 @default.
• W3132169997 cites W2774383511 @default.
• W3132169997 cites W2789500132 @default.
• W3132169997 cites W2793162366 @default.
• W3132169997 cites W2799607950 @default.
• W3132169997 cites W2799891707 @default.
• W3132169997 cites W2902121491 @default.
• W3132169997 cites W2936110479 @default.
• W3132169997 cites W2970670843 @default.
• W3132169997 cites W2971140753 @default.
• W3132169997 doi "https://doi.org/10.3390/nu13020693" @default.
• W3132169997 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7926808" @default.
• W3132169997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33671493" @default.
• W3132169997 hasPublicationYear "2021" @default.
• W3132169997 type Work @default.
• W3132169997 sameAs 3132169997 @default.
• W3132169997 citedByCount "11" @default.
• W3132169997 countsByYear W31321699972021 @default.
• W3132169997 countsByYear W31321699972022 @default.
• W3132169997 countsByYear W31321699972023 @default.
• W3132169997 crossrefType "journal-article" @default.
• W3132169997 hasAuthorship W3132169997A5012008021 @default.
• W3132169997 hasAuthorship W3132169997A5012677271 @default.
• W3132169997 hasAuthorship W3132169997A5016410321 @default.
• W3132169997 hasAuthorship W3132169997A5027463044 @default.
• W3132169997 hasAuthorship W3132169997A5042183753 @default.
• W3132169997 hasAuthorship W3132169997A5084359125 @default.
• W3132169997 hasAuthorship W3132169997A5084461411 @default.
• W3132169997 hasBestOaLocation W31321699971 @default.
• W3132169997 hasConcept C100544194 @default.
• W3132169997 hasConcept C118552586 @default.
• W3132169997 hasConcept C126322002 @default.
• W3132169997 hasConcept C168563851 @default.
• W3132169997 hasConcept C187212893 @default.
• W3132169997 hasConcept C203014093 @default.
• W3132169997 hasConcept C205778803 @default.
• W3132169997 hasConcept C2775871700 @default.
• W3132169997 hasConcept C2779150110 @default.
• W3132169997 hasConcept C2779936771 @default.
• W3132169997 hasConcept C2780206646 @default.
• W3132169997 hasConcept C2780305828 @default.
• W3132169997 hasConcept C3020294031 @default.
• W3132169997 hasConcept C31903555 @default.
• W3132169997 hasConcept C42407357 @default.
• W3132169997 hasConcept C539455810 @default.
• W3132169997 hasConcept C543025807 @default.
• W3132169997 hasConcept C55493867 @default.
• W3132169997 hasConcept C71924100 @default.
• W3132169997 hasConcept C86803240 @default.
• W3132169997 hasConcept C90924648 @default.
• W3132169997 hasConceptScore W3132169997C100544194 @default.
• W3132169997 hasConceptScore W3132169997C118552586 @default.
• W3132169997 hasConceptScore W3132169997C126322002 @default.
• W3132169997 hasConceptScore W3132169997C168563851 @default.
• W3132169997 hasConceptScore W3132169997C187212893 @default.
• W3132169997 hasConceptScore W3132169997C203014093 @default.
• W3132169997 hasConceptScore W3132169997C205778803 @default.
• W3132169997 hasConceptScore W3132169997C2775871700 @default.
• W3132169997 hasConceptScore W3132169997C2779150110 @default.
• W3132169997 hasConceptScore W3132169997C2779936771 @default.

• next